News | May 23, 2021
Orchid Pharma develops new molecule OCID-5090
Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.
Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power
Applied Biosystems CoviPath COVID-19 RT-PCR Kit is approved for in vitro diagnostic use by ICMR and DCGI.
Viruses evolve into new strains when there is a change to their genetic composition.
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
As the Clinical Head of Oncology Network, he lead a team of over 25 specialised oncologists
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
Subscribe To Our Newsletter & Stay Updated
